COMPANY
Provid Pharmaceuticals Inc.
NIH awards 9
- NIH award 1R43CA177002-01A1 FY2014: $224,960 awarded for that fiscal year; activity R43 (SBIR); PI OLSON, GARY L; recipient as written: PROVID PHARMACEUTICALS, INC, MONMOUTH JUNCTION, NJ. TRAIL Upregulation by TIC10 source ↗
- NIH award 1R43HL103037-01 FY2010: $175,200 awarded for that fiscal year; activity R43 (SBIR); PI OLSON, GARY L; recipient as written: PROVID PHARMACEUTICALS, INC, MONMOUTH JUNCTION, NJ. F11R antagonists for atheroscl source ↗
- NIH contract (government contract; not a grant and not an investment round) 261200800025C-0-0-1 FY2008: $149,558 awarded for that fiscal year; activity N43 (OTHER_NIH); PI n/a; recipient as written: PROVID PHARMACEUTICALS, INC, MONMOUTH JUNCTION, NJ. 402 - RFP source ↗
- NIH award 3R43NS048731-01S1 FY2007: $67,410 awarded for that fiscal year; activity R43 (SBIR); PI OLSON, GARY L; recipient as written: PROVID PHARMACEUTICALS, INC, NORTH BRUNSWICK, NJ. MHC Class II inhibitors for Mul source ↗
- NIH award 1R43DK071351-01 FY2005: $106,881 awarded for that fiscal year; activity R43 (SBIR); PI OLSON, GARY L; recipient as written: PROVID PHARMACEUTICALS, INC, NORTH BRUNSWICK, NJ. Design and Assay of DQ2 Inhibito source ↗
- NIH award 1R43HL079788-01 FY2005: $132,414 awarded for that fiscal year; activity R43 (SBIR); PI BURNS-HAMURO, LORA L; recipient as written: PROVID PHARMACEUTICALS, INC, NORTH BRUNSWICK, NJ. Inhibitors of Protein Kin source ↗
- NIH award 1R43NS048731-01 FY2004: $109,997 awarded for that fiscal year; activity R43 (SBIR); PI OLSON, GARY L; recipient as written: PROVID PHARMACEUTICALS, INC, NORTH BRUNSWICK, NJ. MHC Class II inhibitors for Mult source ↗
- NIH award 1R41NS048700-01 FY2004: $187,995 awarded for that fiscal year; activity R41 (STTR); PI BURKE, JAMES R; recipient as written: PROVID PHARMACEUTICALS, INC, NORTH BRUNSWICK, NJ. QBP1 Mimetics as Therapeutics f source ↗
- NIH award 1R43AI052940-01 FY2002: $268,433 awarded for that fiscal year; activity R43 (SBIR); PI SELF, CHRISTOPHER RAYMOND; recipient as written: PROVID PHARMACEUTICALS, INC, NORTH BRUNSWICK, NJ. Antibacterial RNA Po source ↗